The Second Edition of “The Milan System for Reporting Salivary Gland Cytopathology,” much like its predecessor, stands as a collaborative endeavor driven by a multidisciplinary group comprising cytopathologists, surgical pathologists, molecular pathologists, radiologists, and head and neck surgeons. This international collective shares a common objective: the establishment of a pragmatic and standardized reporting system for fine needle aspiration (FNA) of salivary glands. The book’s structure revolves around six overarching diagnostic categories: “Non-Diagnostic,” “Non-Neoplastic,” “Atypia of Undetermined Significance (AUS),” “Neoplasm: Benign,” “Neoplasm: Salivary Gland Neoplasm of Uncertain Malignant Potential (SUMP),” “Suspicious for Malignancy,” and “Malignant.” Each category is meticulously defined, encompassing morphologic criteria and elucidations.
Incorporating the most up-to-date ancillary studies, radiologic characteristics of salivary gland lesions, clinical management insights, and histological considerations – including updates from the recent 5th Edition WHO blue book – the book goes beyond mere categorization. It empowers practitioners with a comprehensive understanding of the subject matter.
“The Milan System for Reporting Salivary Gland Cytopathology 2nd Edition” marks a significant stride towards enhancing the efficacy of salivary gland FNA procedures. It aims to facilitate enhanced communication not only between clinicians but also across institutions, ultimately resulting in improved patient care outcomes. This edition serves as an indispensable resource for healthcare professionals involved in the intricate realm of salivary gland cytopathology.
